Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 16, 2008

Primary Completion Date

March 3, 2014

Study Completion Date

March 3, 2014

Conditions
AnemiaChronic Kidney DiseaseKidney Disease
Interventions
DRUG

Darbepoetin Alfa

Administered by subcutaneous or intravenous injection

DRUG

Placebo

Matching placebo solution for subcutaneous or intravenous injection to maintain the blind in the Q2W arm.

Trial Locations (67)

2015

Research Site, Jūrmala

2650

Research Site, Edegem

3000

Research Site, Leuven

9000

Research Site, Ghent

10029

Research Site, New York

10467

Research Site, The Bronx

10595

Research Site, Valhalla

11040

Research Site, New Hyde Park

14222

Research Site, Buffalo

19104

Research Site, Philadelphia

20010

Research Site, Washington D.C.

20230

Research Site, Aguascalientes

21287

Research Site, Baltimore

22908

Research Site, Charlottesville

23219

Research Site, Richmond

23507

Research Site, Norfolk

28203

Research Site, Charlotte

31000

Research Site, Chihuahua City

32610

Research Site, Gainesville

32806

Research Site, Orlando

33136

Research Site, Miami

35233

Research Site, Birmingham

40202

Research Site, Louisville

43205

Research Site, Columbus

44106

Research Site, Cleveland

44195

Research Site, Cleveland

44308

Research Site, Akron

45229

Research Site, Cincinnati

52242

Research Site, Iowa City

60612

Research Site, Chicago

64108

Research Site, Kansas City

70118

Research Site, New Orleans

72190

Research Site, Puebla City

75390

Research Site, Dallas

77030

Research Site, Houston

78229

Research Site, San Antonio

83712

Research Site, Boise

87131

Research Site, Albuquerque

90027

Research Site, Los Angeles

90095

Research Site, Los Angeles

92123

Research Site, San Diego

94143

Research Site, San Francisco

97227

Research Site, Portland

97239

Research Site, Portland

98105

Research Site, Seattle

107014

Research Site, Moscow

117997

Research Site, Moscow

198205

Research Site, Saint Petersburg

350033

Research Site, Krasnodar

443095

Research Site, Samara

460004

Research Site, Orenburg

94305-5208

Research Site, Stanford

02115

Research Site, Boston

07039

Research Site, Livingston

08901

Research Site, New Brunswick

08406

Research Site, Vilnius

06720

Research Site, Mexico City

80-952

Research Site, Gdansk

93-338

Research Site, Lodz

70-410

Research Site, Szczecin

00935

Research Site, San Juan

974 09

Research Site, Banská Bystrica

833 40

Research Site, Bratislava

040 11

Research Site, Košice

B4 6NH

Research Site, Birmingham

LS1 3EX

Research Site, Leeds

SE1 7EH

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY